Position in CURLF
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$134,270,588
+$93,968,303 QoQ
Shares Held
12,420,961
+256.0% QoQ
Ownership
4.69%
of shares outstanding
% of Portfolio
23.61%
of 13F equity value
Holder Rank
#1
of 6 holders
Holding Since
Mar 2024
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CURLF Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026AdvisorShares Investments LLC holds $261,923,894 across 17 Drug Manufacturers - Specialty & Generic names. CURLF ranks #1 (51.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CURLF |
Curaleaf Holdings, Inc.
This page
|
12,420,961 | $134,270,588 | |
| 2 | TRLV |
Trulieve Cannabis Corp.
|
10,641,152 | $104,602,524 | |
| 3 | GLAS |
Glass House Brands Inc.
|
850,000 | $11,050,000 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
11,553 | $1,947,142 | |
| 5 | ALKS |
Alkermes plc.
|
36,438 | $1,909,351 | |
| 6 | CRON |
Cronos Group Inc.
|
482,394 | $1,341,055 | |
| 7 | SUPN |
Supernus Pharmaceuticals, Inc.
|
27,618 | $1,284,513 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
32,883 | $1,114,076 |
All Filings in CURLF
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $134,270,588 | 12,420,961 | Shares | Sole | 2026-08-11 | |
| 2024-06-30 | $40,302,285 | 10,468,126 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $49,942,937 | 9,352,610 | Shares | Sole | 2024-05-14 | |
| No filing history on record for this holder in this stock. | ||||||